Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,404.00
Bid: 12,404.00
Ask: 12,406.00
Change: 44.00 (0.36%)
Spread: 2.00 (0.016%)
Open: 12,330.00
High: 12,422.00
Low: 12,316.00
Prev. Close: 12,360.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Hargreaves Lansdown falls on higher costs warning

Mon, 09th Aug 2021 08:49

(Alliance News) - Stock prices in London opened lower on Monday as investors grew more concerned over the spread of the Delta variant of Covid-19, while Hargreaves Lansdown shares slipped after warning on higher costs and earnings missing forecasts.

The FTSE 100 index was down 13.70 points, or 0.2%, at 7,109.25. The mid-cap FTSE 250 index was down 71.66 points, or 0.3%, at 23,385.66. The AIM All-Share index was down 0.2% at 1,259.76.

The Cboe UK 100 index was down 0.2% at 708.30. The Cboe 250 was down 0.4% at 21,180.35, and the Cboe Small Companies flat at 15,405.34.

In mainland Europe, the CAC 40 in Paris and DAX 30 in Frankfurt were both up 0.1%.

In the FTSE 100, AstraZeneca was up 0.8% after Morgan Stanley resumed coverage on the Anglo-Swedish drugmaker with an Overweight rating. In addition, AstraZeneca said it Forxiga drug was approved in the EU for treatment of chronic kidney disease.

At the other end of the large-caps, Hargreaves Lansdown was the worst performer, down 8.8%, even as the fund supermarket reported positive annual results.

For the financial year that ended June 30, revenue rose 15% to GBP631.0 million from GBP550.9 million last year, but pretax profit was GBP366.0 million, down 3.0% from GBP378.3 million. The revenue and profit figures missed consensus estimates from Jefferies of GBP636.7 billion and GBP383.0 million respectively.

The Bristol-based firm reported strong growth in assets under administration, which were up 30% to GBP135.5 billion from GBP104.0 billion. Net new business inflows were up 13% to GBP8.7 billion from GBP7.7 billion. However, this also missed Jefferies forecasts of GBP136.3 billion and GBP9.2 billion respectively.

Looking ahead, Chief Executive Officer Chris Hill said: "With this continued investment in our people, proposition, service and technology as well as the cost of servicing an enlarged and growing client base, we expect 2022 costs to reflect this investment and continue to be broadly aligned to client growth."

Hargreaves Lansdown also warned it has seen a slowdown in dealing volumes and client activity versus the elevated levels at the time last year.

"While market share increased marginally and retention remains 92% on a client numbers and AUA basis, the problem of having more, less profitable, clients is emerging. With new and aggressive competitors joining the UK market, revenue margins falling and costs rising, financial 2022 will see these trends continue. Despite strong client recruitment and retention and clear market leadership, we think HL may be vulnerable," said analysts at Jefferies.

In the FTSE 250, Vectura Group was up 2.3% at 167.80 pence after Philip Morris International raised its bid for asthma treatment firm to 165 pence per share.

The Marlboro cigarette maker's offer bested the 155p offer from private equity firm Carlyle to which Vectura had agreed on Friday. The new offer values Vectura at GBP1.02 billion. PMI previously had offered 150p per Vectura share.

Clarkson was up 2.0% after the shipping services provider reported a robust set of interim earnings, with strong trading across all areas of the business.

For the six months to June 30, revenue was GBP190.1 million, up 5.4%, GBP180.4 million last year, and pretax profit rose 31% to GBP27.3 million from GBP20.9 million.

The company declared an interim dividend of 27p, up 8% from 25p paid out at the halfway stage last year.

Elsewhere, Deliveroo was up 5.3% after Germany's Delivery Hero built a 5.1% stake in its UK rival, crossing the 5% threshold on Friday, according to a regulatory release on Monday. Delivery Hero was 0.1% lower in Frankfurt.

In China on Monday, the Shanghai Composite closed up 1.0%, while the Hang Seng index in Hong Kong was up 0.5%. Financial markets in Japan were closed on Monday for the Mountain Day holiday. The S&P/ASX 200 in Sydney finished flat.

Chinese factory inflation rose by more than expected in July, data showed Monday, as surging commodity prices offset government measures to temper costs.

The producer price index, which measures the cost of goods at the factory gate, rose to 9.0% on-year, the same as May, which was a 13-year high, according to the National Bureau of Statistics.

While the PPI remains elevated, consumer inflation ticked down to 1.0% in July, with officials stressing their work to stabilise prices in the wake of recent disasters including floods in central China and with companies appearing to absorb the increases instead of passing them on to consumers.

The pound was quoted at USD1.3887 early Monday, up from USD1.3862 at the London equities close Friday.

The euro was priced at USD1.1755, marginally lower from USD1.1760. Against the Japanese yen, the dollar was trading at JPY110.12, down from JPY110.30.

Brent oil was quoted at USD69.00 a barrel Monday morning, down sharply from USD70.92 late Friday. Gold was trading at USD1,745.26 an ounce, down from USD1,764.55.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
20 May 2024 08:24

TOP NEWS: AstraZeneca plans to build manufacturing plant in Singapore

(Alliance News) - AstraZeneca PLC on Monday announced plans for a USD1.5 billion manufacturing facility in Singapore to produce antibody drug conjugates, treatments that deliver "highly potent cancer-killing agents".

Read more
20 May 2024 07:47

LONDON BRIEFING: Keywords would back GBP2.0 billion bid as EQT circles

(Alliance News) - London's FTSE 100 is called to open higher at the start of the week, while the pound climbed and gold hit another record high, with investors hopeful the Federal Reserve could soon cut US interest rates.

Read more
20 May 2024 07:22

AstraZeneca announces $1.5bn Singapore manufacturing facility

(Sharecast News) - AstraZeneca announced plans to construct a $1.5bn manufacturing facility in Singapore on Monday, dedicated to the production of antibody drug conjugates (ADCs).

Read more
17 May 2024 22:25

Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial

May 17 (Reuters) - AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its Wyeth unit's patent rights.

Read more
16 May 2024 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.